L
Lineage Cell Therapeutics Inc
XBER:BT3
Lineage Cell Therapeutics Inc
XBER:BT3
Price:
1.35
EUR
Market Cap:
€395.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCG
|
SE |
|
Polski Koncern Naftowy Orlen SA
F:PKY1
|
PL |
|
F
|
Flywire Corp
NASDAQ:FLYW
|
US |
|
C
|
CareCloud Inc
NASDAQ:CCLD
|
US |
|
S
|
Snam SpA
OTC:SNMRY
|
IT |
|
C
|
Celanese Corp
LSE:0HUR
|
US |
|
Euroseas Ltd
NASDAQ:ESEA
|
GR |
|
HeadHunter Group PLC
MOEX:HHRU
|
CY |
|
K
|
Komatsu Ltd
XMUN:KOM1
|
JP |
|
W
|
Weiqiao Textile Co Ltd
HKEX:2698
|
CN |
|
P
|
Prudential PLC
XHAM:PRU
|
UK |
|
Thomson Reuters Corp
F:TOC
|
CA |
|
Software Service Inc
OTC:SFSVF
|
JP |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.35 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
